LIVER CONTRAST ENHANCEMENT IN PRIMATES USING IOPROMIDE LIPOSOMES

被引:13
|
作者
SCHMIEDL, UP [1 ]
KRAUSE, W [1 ]
LEIKE, J [1 ]
NELSON, JA [1 ]
SCHUHMANNGIAMPIERI, G [1 ]
机构
[1] SCHERING AG,INST CONTRAST MEDIA RES,W-1000 BERLIN,GERMANY
关键词
LIPOSOMES; HEPATIC COMPUTED TOMOGRAPHY; CONTRAST ENHANCEMENT;
D O I
10.1016/S1076-6332(05)80697-X
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Rationale and Objectives. We studied the feasibility of using iodinated liposomes as computed tomography (CT) liver contrast agents in nonhuman primates. Methods. Iopromide-containing liposomes were investigated as reticuloendothelial (RES) contrast agents for CT scanning of the liver in normal adult baboons. For intravenous (IV) injection, liposomes were resuspended in mannitol solution, filtered under sterile conditions, and injected TV at doses of 200 and 400 mg I/kg to each of five anesthetized adult baboons. Results. Animals tolerated the injections without measurable electrocardiographic changes and recovered uneventfully from anesthesia. Sequential CT scans of the baboons' upper abdomen acquired up to 60 min postinjection showed persistent enhancement of the Liver 10-60 min after injection. Maximum enhancement levels were 36 and 61 Delta Hounsfield units (Delta H) after the 200- and 400-mg/kg doses, respectively. The mean time to plateau enhancement was 20 min with the 200-mg/kg dose and 10 min with the 400-mg/kg dose. The greatest splenic enhancements were 181 and 301 Delta H after the 200- and 400-mg/kg doses, respectively. Conclusion. Iopromide liposomes are effective as RES contrast agents in primates.
引用
收藏
页码:967 / 972
页数:6
相关论文
共 50 条
  • [41] USE OF NONIONIC CONTRAST-MEDIA - TRENDS AND EXPERIENCE WITH IOPROMIDE
    SCHILD, HH
    INVESTIGATIVE RADIOLOGY, 1994, 29 : S112 - S117
  • [42] CONTRAST-MEDIUM SIDE-EFFECTS IN PHLEBOGRAPHY WITH IOPROMIDE
    LANGER, M
    LANGER, R
    BEHRENDS, B
    ZWICKER, C
    EICHSTADT, H
    FELIX, R
    PHLEBOLOGY 89: PROCEEDINGS OF THE 10TH WORLD CONGRESS OF THE UNION-INTERNATIONALE-DE-PHLEBOLOGIE, 1989, : 426 - 428
  • [43] Contrast-induced monoplegia following coronary angioplasty with iopromide
    Aykan, Ahmet
    Zehir, Regayip
    Karabay, Can Yucel
    Kocabay, Gonenc
    KARDIOLOGIA POLSKA, 2012, 70 (05) : 499 - 500
  • [44] Kounis Syndrome after Administration of Iopromide-Based Contrast
    Wong, Shiun Woei
    Hatib, Alimi Ahmad
    ACTA CARDIOLOGICA SINICA, 2023, 39 (04) : 667 - 669
  • [45] Comparative evaluation of the formulation, characterization, stability and in vitro release of iopromide liposomes and niosomes
    Erdogan, S
    Ozer, AY
    Hincal, AA
    STP PHARMA SCIENCES, 1998, 8 (02): : 127 - 132
  • [46] Enhancement of Heterogeneous Assays Using Fluorescent Magnetic Liposomes
    Edwards, Katie A.
    Baeumner, Antje J.
    ANALYTICAL CHEMISTRY, 2014, 86 (13) : 6610 - 6616
  • [47] Size-induced enhancement of chemical exchange saturation transfer (CEST) contrast in liposomes
    Zhao, Jason M.
    Har-el, Yah-El
    McMahon, Michael T.
    Zhou, Jinyuan
    Sherry, A. Dean
    Sgouros, George
    Bulte, Jeff W. M.
    van Zijl, Peter C. M.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (15) : 5178 - 5184
  • [48] GADOLINIUM-LABELED LIPOSOMES - TARGETED MR CONTRAST AGENTS FOR THE LIVER AND SPLEEN
    KABALKA, G
    BUONOCORE, E
    HUBNER, K
    MOSS, T
    NORLEY, N
    HUANG, L
    RADIOLOGY, 1987, 163 (01) : 255 - 258
  • [49] MRI Contrast Enhancement of Liver Pre-neoplasia Using Iron-Tannic Nanoparticles
    Pilapong, Chalermchai
    Phatruengdet, Thipjutha
    Intakhat, Janarong
    Tapunya, Monreudee
    Chariyakornkul, Arpamas
    Hlaing, Chi Be
    Wongpoomchai, Rawiwan
    CANCER SCIENCE, 2021, 112 : 522 - 522
  • [50] MRI contrast enhancement of liver pre-neoplasia using iron-tannic nanoparticles
    Phatruengdet, Thipjutha
    Intakhad, Jannarong
    Tapunya, Monreudee
    Chariyakornkul, Arpamas
    Hlaing, Chi Be
    Wongpoomchai, Rawiwan
    Pilapong, Chalermchai
    RSC ADVANCES, 2020, 10 (58) : 35419 - 35425